The statements contained herein that are not historical facts are forward-looking statements based on management's current expectations and beliefs concerning future developments and their potential effects on the Company. Such statements involve inherent risks and uncertainties, many of which are difficult to predict and are generally beyond our control. There can be no assurance that future developments affecting us will be the same as those anticipated by management. We caution readers that a number of i ...

Financial Performance - ASML reported total net sales of €7.5 billion in Q3 2025[1] - The company's net income for Q3 2025 was €2.1 billion[1] - Gross margin for Q3 2025 was 51.6%[6] - Net system sales in Q3 2025 amounted to €5.6 billion[6] - Installed Base Management sales reached €2.0 billion in Q3 2025[6] - Net bookings for Q3 2025 were €5.4 billion, including €3.6 billion from EUV bookings[6] Outlook - ASML anticipates full-year 2025 total net sales growth of around 15% with a gross margin of approximately 52%[1] - Q4 2025 total net sales are expected to be between €9.2 billion and €9.8 billion[26] Market and Strategy - The semiconductor industry is projected to exceed $1 trillion in revenue by 2030, driven by AI adoption[4] - ASML sees an opportunity to achieve annual revenue between approximately €44 billion and €60 billion by 2030, with a gross margin between approximately 56% and 60%[4]

THIRD-QUARTER 2025 RESULTS $5.4B MEDICAL DEVICES $1.5B ESTABLISHED $2.2B NUTRITION $5.12 to $5.183 REAFFIRMED FULL-YEAR GUIDANCE TOTAL COMPANY SALES $11.4B +7.5%1 Organic* sales growth for underlying base business** ADJUSTED DILUTED EPS $1.302 KEY BUSINESS UNITS ADJUSTED DILUTED EPS Narrowed range reflects double-digit growth at the midpoint 7.5% to 8.0%3 ORGANIC SALES GROWTH Excluding COVID-19 testing-related sales BUSINESS HIGHLIGHTS EXPANDING ALTERNATIVES TO OPEN-HEART SURGERY EXTENDING GLOBAL REACH OF S ...

Safe Harbor and Forward-Looking Statements This release contains forward-looking statements within the meaning of the federal securities laws. These statements include, but are not limited to statements regarding Vontier Corporation's (the "Company's") anticipated sales growth and anticipated adjusted net earnings per share, and any other statements identified by their use of words like "anticipate," "expect," "believe," "outlook," "guidance," or "will" or other words of similar meaning. There are a number ...

Financial Performance - Net income available to common stockholders was $457 million, a 14% increase QoQ and a 33% increase YoY[8] - Diluted earnings per share (EPS) reached $1.05, up 14% QoQ and 36% YoY[8] - Pre-provision profit (PPNR) increased by 9% QoQ and 20% YoY, reaching $783 million[8, 13] - Total revenue was $2.118 billion, up 4% QoQ and 11% YoY[8] - Net interest income (NII) was $1.488 billion, up 4% QoQ and 9% YoY[8] - Noninterest income was $630 million, up 5% QoQ and 18% YoY[8] Key Metrics - Net interest margin (NIM) increased by 5 bps QoQ to 3.00%[8] - Efficiency ratio improved by approximately 170 bps QoQ to 63.0%[8, 14] - Return on tangible common equity (ROTCE) was 11.7%, up 70 bps QoQ[8, 14] Balance Sheet and Capital - Average deposits increased by approximately $2 billion, or 1% QoQ, to $176 billion[8, 14] - Period-end loans increased by 1% QoQ[14] - Common Equity Tier 1 (CET1) ratio was 10.7%[14]

Bank of America 3Q25 Financial Results October 15, 2025 3Q25 Highlights | Balance Sheet Strength | Revenue Growth | Earnings Growth | | --- | --- | --- | | Deposits $2.0T1 | Revenue $28.1B4 | Net income $8.5B | | +4% YoY | +11% YoY | +23% YoY | | Loans $1.2T1 | Net interest income | EPS $1.065 | | +8% YoY | +9% YoY | +31% YoY | | CET1 11.6% | Sales & trading | Operating leverage6 | | well above reg. min.2 | +9% YoY | 5.6% | | Robust liquidity | IB fees | Efficiency ratio | | GLS $961B3 | +43% YoY | 62% | | ...

GCM Grosvenor ("GCMG") Investor Day October 15, 2025 GCM GROSVENOR | Welcome & Opening Remarks Stacie Selinger Head of Investor Relations GCM GROSVENOR | FORWARD-LOOKING STATEMENTS AND OTHER DISCLOSURES This presentation has been prepared by GCM Grosvenor Inc. solely for informational purposes for its public stockholders and other stakeholders in connection with evaluating the business, operations and financial results of GCM Grosvenor. This presentation is not intended to and does not constitute an offer t ...

Q2 2026 Earnings Presentation October 15, 2025 1 Today's Presenters Zak Calisto Group CEO & Founder Goy Hoeshin Group CFO Carmen Calisto Group Chief Strategy & Marketing Officer 2 2 DISCLAIMER Forward-Looking Statements The information in this presentation (which includes any oral statements made in connection therewith, as applicable) includes "forward-looking statements." Forward-looking statements are based on our beliefs and assumptions and on information currently available to us, and include, without ...

THIRD QUARTER 2025 FINANCIAL RESULTS October 15, 2025 Disclaimers Cautionary Statement Regarding Forward-Looking Statements The following slides are part of a presentation by Synchrony Financial in connection with reporting quarterly financial results and should be read in conjunction with the earnings release and financial supplement included as exhibits to our Current Report on Form 8-K filed today and available on our website (www.investors.synchrony.com) and the SEC's website (www.sec.gov). All referenc ...

Business Update October 15, 2025 Forward-Looking Statements Today's presentation includes forward-looking statements that reflect Bunge's current views with respect to future events, financial performance and industry conditions. These forward-looking statements are subject to various risks and uncertainties. Bunge has provided additional information in its reports on file with the Securities and Exchange Commission concerning factors that could cause actual results to differ materially from those contained ...